NCT03418818View on ClinicalTrials.gov

FAZA PET/MRI Sarcoma

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Sarcoma
Interventions
DRUG

18F-FAZA

18F-FAZA is a radiotracer used for PET imaging (in combination with MRI) to detect hypoxia in tumours. This scan will be done before and after their radiation treatment.

DRUG

Pimonidazole

Pimonidazole is a drug that will attached to areas in the tumour that are low in oxygen. When this occurs, the areas of the tumour that are low in oxygen can be more easily found and studied after surgical removal.

Trial Locations (1)

L4W4C2

RECRUITING

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER